Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

XENE Xenon Pharmaceuticals

Watchlist
39.190
+0.850+2.22%
Close  02/03 16:00 ET
39.1900.0000.00%
Post Mkt Price 02/03 16:01 ET
High
39.490
Open
38.140
Turnover
8.10M
Low
37.910
Pre Close
38.340
Volume
207.57K
Market Cap
2.45B
P/E(TTM)
Loss
52wk High
41.390
Shares
62.54M
P/E(Static)
Loss
52wk Low
24.940
Float Cap
2.23B
Bid/Ask %
-33.33%
Historical High
41.390
Shs Float
56.81M
Volume Ratio
0.57
Historical Low
2.100
Dividend TTM
--
Div Yield TTM
--
P/B
3.25
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.37%
Amplitude
4.12%
Avg Price
39.041
Lot Size
1
Float Cap
2.23B
Bid/Ask %
-33.33%
Historical High
41.390
Shs Float
56.81M
Volume Ratio
0.57
Historical Low
2.100
Dividend TTM
--
P/B
3.25
Dividend LFY
--
Turnover Ratio
0.37%
Amplitude
4.12%
Avg Price
39.041
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Xenon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.
CEO: Mr. Ian C. Mortimer
Market: NASDAQ
Listing Date: 11/05/2014
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist